Carotenoids are currently under intense scrutiny regarding their poten
tial to modulate chronic disease risk and prevent vitamin A deficiency
, and renewed emphasis has been placed on achieving a better understan
ding of the metabolic fate of these compounds in humans, The developme
nt of new animal models, and use of human metabolic studies and stable
tracer methods have greatly improved our knowledge of how carotenoids
are absorbed, metabolized, and transported to tissues; however, many
important issues remain unresolved, For example, intestinal uptake of
carotenoids occurs by passive diffusion, but the lumenal or intracellu
lar factors limiting this process are obscure, The intestinal mucosa p
lays a key role in the metabolism of provitamin A carotenoids such as
beta-carotene, thus greatly influencing their bioavailability, Most re
cent evidence supports a central oxidation mechanism of cleavage of be
ta-carotene to retinal in the intestinal mucosa, but the extent and si
te(s) of postabsorptive metabolism in the human is unknown, While the
human and other species clearly absorb non-provitamin A carotenoids, l
ittle is known of the extent and pathways of their metabolism and elim
ination, The metabolic fate of cis isomers of beta-carotene is a subje
ct of recent interest, since 9-cis retinoic acid can apparently be for
med from 9-cis beta-carotene hl vitro and in vivo, Substantial cis-tra
ns isomerization of at least small oral doses of 9-cis beta-carotene o
ccurs in the human, although the site of isomerization is not yet know
n, Carotenoids are transported in plasma exclusively by lipoproteins,
with the distribution among lipoprotein classes determined in large pa
rt by the physical properties of the carotenoid, The consequences of d
ifferential distribution in terms of tissue uptake and retention are n
ot clear at present, Improved knowledge of the metabolic fate of carot
enoids will assist in the development and testing of hypotheses regard
ing their potential to influence biological processes in the human.